Consistent with neutrophil dominant inflammation in CF, the most significant gene expression changes upon ETI reflected a major decrease in neutrophil-specific gene expression, including markers of neutrophil activation (TLR4, CXCR1, CXCR2) (36). The gene discussed is CXCR2; the disease is cystic fibrosis.